AstraZeneca says booster jab effective against Omicron

Published December 24, 2021
People pose with a needle in front of displayed AstraZeneca logo in this illustration taken December 11. — Reuters
People pose with a needle in front of displayed AstraZeneca logo in this illustration taken December 11. — Reuters

LONDON: British pharmaceutical giant AstraZeneca said on Thursday that a third, or “booster”, dose of its Covid-19 vaccine Vaxzevria “significantly” lifted antibody levels against the Omicron strain in a laboratory study.

AstraZeneca also revealed in other findings that its preventative moniclonal antibody treatment, Evusheld, “retains neutralisation activity” against Omicron.

The threat of the highly transmissible Omicron variant looms large over the festive holidays, forcing many governments to roll out new curbs and urge citizens to get vaccinated. However, separate UK research on Thursday suggested that Omicron infections are less likely to result in hospitalisation compared to the Delta variant.

“Vaxzevria significantly boosted levels of antibodies against the Omicron SARS-CoV-2 variant (B.1.1.529) following a third dose booster,” AstraZeneca said in a statement.

“The third dose booster vaccination neutralised the Omicron variant to levels that were broadly similar to those observed... after the second dose against the Delta variant.” Levels of neutralising antibodies were also higher with the booster jab than with individuals who had previously been infected and recovered naturally.

The study was conducted by investigators from the University of Oxford, which is the academic institution which helped AstraZeneca develop the vaccine last year.

Researchers analysed blood samples taken from individuals infected with Covid-19; those vaccinated with two doses plus a booster; and those who had reported previous infection. “It is very encouraging to see that current vaccines have the potential to protect against Omicron following a third dose booster,” said University of Oxford professor John Bell, one of the study investigators.

Published in Dawn, December 24th, 2021

Opinion

Editorial

Taking cover
Updated 09 Jan, 2025

Taking cover

IT is unfortunate that, instead of taking ownership of important decisions, our officials usually seem keener to ...
A living hell
09 Jan, 2025

A living hell

WHAT Donald Trump does domestically when he enters the White House in just under two weeks is frankly the American...
A right denied
09 Jan, 2025

A right denied

DESPITE citizens possessing the constitutional and legal right to access it, federal ministries are failing to...
Closed doors
Updated 08 Jan, 2025

Closed doors

The nation’s fate has been decided through secret deals for too long, with the result that the citizenry has become increasingly alienated from the state.
Debt burden
08 Jan, 2025

Debt burden

THE federal government’s total debt stock soared by above 11pc year-over-year to Rs70.4tr at the end of November,...
GB power crisis
08 Jan, 2025

GB power crisis

MASS protests are not a novelty in Pakistan, and when the state refuses to listen through the available channels —...